AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹13 Cr | ₹-18 Cr | ₹8.89 Cr | ₹5.72 Cr | ₹11 Cr |
What is the latest Cash Flow from Operating Activities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹13 Cr |
| Mar2025 | ₹-18 Cr |
| Mar2024 | ₹8.89 Cr |
| Mar2023 | ₹5.72 Cr |
| Mar2022 | ₹11 Cr |
How is Cash Flow from Operating Activities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹13 Cr | Positive | |
| Mar2025 | ₹-18 Cr | Negative | |
| Mar2024 | ₹8.89 Cr | 55.23 | |
| Mar2023 | ₹5.72 Cr | -50.10 | |
| Mar2022 | ₹11 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹316.2 Cr | -11.5% | 31.7% | 40.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -11.5% |
31.7% |
40.9% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses